NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-203-2020-0-HK-11 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY HK EP 62022057259.3 Pending
NIBIB E-062-2017-0-US-08 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA
MULTIVIEW IMAGING 		US CON 17/814,096 1168-09-03 Issued PDF
NCI E-169-2018-0-US-06 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE US National Stage 17/794,212 Pending
NIAID E-007-2015-0-NO-01 CD47-targeted Therapies For The Treatment Of Infectious Disease NO EP 22185801.2 Issued
NIAID E-007-2015-0-PL-01 CD47-targeted Therapies For The Treatment Of Infectious Disease PL EP 22185801.2 Issued
NIAID E-007-2015-0-ES-01 CD47-targeted Therapies For The Treatment Of Infectious Disease ES EP 22185801.2 Issued
NIAID E-007-2015-0-SK-01 CD47-targeted Therapies For The Treatment Of Infectious Disease SK EP 22185801.2 Issued
NIAID E-007-2015-0-CZ-01 CD47-targeted Therapies For The Treatment Of Infectious Disease CZ EP 22185801.2 Issued
NIAID E-007-2015-0-TR-01 CD47-targeted Therapies For The Treatment Of Infectious Disease TR EP 22185801.2 Issued
NIAID E-007-2015-0-CH-01 CD47-targeted Therapies For The Treatment Of Infectious Disease CH EP 22185801.2 Issued
NIAID E-007-2015-0-GB-01 CD47-targeted Therapies For The Treatment Of Infectious Disease GB EP 22185801.2 Issued
NIAID E-007-2015-0-IE-01 CD47-targeted Therapies For The Treatment Of Infectious Disease IE EP 22185801.2 Issued
NIAID E-007-2015-0-GR-01 CD47-targeted Therapies For The Treatment Of Infectious Disease GR EP 22185801.2 Issued
NIAID E-007-2015-0-EP-37 CD47-targeted Therapies For The Treatment Of Infectious Disease EP DIV 22185801.2 Issued
NCI E-159-2019-0-US-06 HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) US National Stage 17/793,753 Pending
NCI E-159-2019-0-CA-03 HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) CA National Stage 3165251 Pending
NCI E-169-2018-0-CA-04 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE CA National Stage 3165120 Pending
NIAID E-184-2022-0-US-01 Novel Compositions Of Matter Comprising Pfs230 Malaria Vaccine Antigens And Anti-Pfs230 Monoclonal Antibodies And Their Use US 63/368,739 Expired
NCI E-044-2022-0-US-01 KINASE INHIBITORS US 63/389,937 Expired
NHLBI E-070-2020-0-US-05 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING US National Stage 17/793,089 Pending
NHLBI E-069-2020-0-US-05 REAL-TIME MONITORING OF INVIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES US National Stage 17/793,083 Pending
NEI E-251-2012-3-US-20 METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS) US DIV 17/812,915 Pending
NCI E-173-2018-2-GB-10 Viral Methods Of T Cell Therapy GB DIV 2210377.4 Issued
NCATS E-116-2016-0-CN-10 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE CN DIV 2022108264642 Pending
NCI E-169-2018-0-AU-03 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE AU National Stage 2021209875 Pending
NICHD E-173-2016-0-US-08 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS US CON 17/863,846 11846690 Issued PDF
NCI E-041-2020-0-US-03 Antisense Oligos That Block Cancer Cell Migration And Invasion US National Stage 17/792,507 Pending
NLM E-107-2010-2-US-37 METHODS OF EPIGENETIC ANALYSIS US CON 17/863,689 Abandoned
NIAID E-157-2022-0-US-01 SARS-CoV-2 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS US 63/388,498 Expired
NLM E-110-2016-2-AU-01 Novel CRISPR Enzymes And Systems AU DIV 2022205165 Pending
NLM E-111-2016-7-AU-01 Novel CRISPR Enzymes And Systems AU DIV 2022205162 Pending
NHLBI E-100-2022-0-US-01 VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS US 63/359,222 Expired
NIDCD E-173-2022-0-US-01 CSF1R INHIBITION INDUCES MACROPHAGE ABLATION AND PROTECTS AGAINST CISPLATIN-INDUCED HEARING LOSS IN MICE US 63/359,593 Expired
NIBIB E-139-2022-0-US-01 Modulation Of Antigen Presentation In Immune Responses To Medical Devices And Regenerative Therapeutics US 63/367,994 Expired
NEI E-164-2021-0-PCT-02 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY PCT PCT PCT/US2022/036420 Expired
NIDCD E-029-2020-0-US-04 USE OF STATINS TO TREAT OR PREVENT DRUG-INDUCED HEARING LOSS US National Stage 17/791,239 Pending
NEI E-164-2021-0-US-03 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY US ORD 17/859,861 Pending
NCI E-158-2022-0-US-01 IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE US 63/358,919 Expired
NCI E-076-2022-0-US-01 CELL-BARCODE RECORDER DEVICE AND METHODS REGARDING SAME US 63/358,933 Expired
NHLBI E-025-2019-0-EP-04 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF EP National Stage 20838695.3 Pending
NCI E-091-2019-0-US-05 METHODS OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS US National Stage 17/790,939 Pending
NIAID E-066-2014-0-EP-27 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF EP DIV 22183051.6 Pending
NCI E-091-2019-0-JP-04 METHOD OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS JP National Stage 2022-541714 Pending
NIA E-135-2022-0-US-01 MONOCLONAL ANTIBODIES DIRECTED TO THREONINE PHOSPHORYLATION OF PSD95 AND USES THEREOF US 63/358,178 Expired
NCI E-175-2016-0-EP-19 ANTI-KRAS-G12D T CELL RECEPTORS EP DIV 22182473.3 Pending
NIDDK E-127-2019-0-EP-03 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4NITRO-1H-IMIDAZOL-5-
YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION 		EP National Stage 20842420.0 Pending
NIAID E-197-2023-0-US-02 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/357,873 Expired
NIAID E-131-2015-2-US-50 NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 17/855,553 Pending
NCI E-199-2023-0-US-02 TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA US ORD 17/854,211 Abandoned
NIAID E-197-2023-0-US-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/357,336 Expired